42 related articles for article (PubMed ID: 2852980)
1. Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells.
Mizuochi T; Spellman MW; Larkin M; Solomon J; Basa LJ; Feizi T
Biomed Chromatogr; 1988 Nov; 2(6):260-70. PubMed ID: 2852980
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
[TBL] [Abstract][Full Text] [Related]
3. The HIV glycan shield as a target for broadly neutralizing antibodies.
Doores KJ
FEBS J; 2015 Dec; 282(24):4679-91. PubMed ID: 26411545
[TBL] [Abstract][Full Text] [Related]
4. Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.
Pritchard LK; Harvey DJ; Bonomelli C; Crispin M; Doores KJ
J Virol; 2015 Sep; 89(17):8932-44. PubMed ID: 26085151
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): an overview.
Férir G; Gordts SC; Schols D
Molecules; 2014 Dec; 19(12):21085-112. PubMed ID: 25517345
[TBL] [Abstract][Full Text] [Related]
6. Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.
Raska M; Czernekova L; Moldoveanu Z; Zachova K; Elliott MC; Novak Z; Hall S; Hoelscher M; Maboko L; Brown R; Smith PD; Mestecky J; Novak J
AIDS Res Ther; 2014; 11():23. PubMed ID: 25120578
[TBL] [Abstract][Full Text] [Related]
7. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
[TBL] [Abstract][Full Text] [Related]
8. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
Kong L; Sheppard NC; Stewart-Jones GBE; Robson CL; Chen H; Xu X; Krashias G; Bonomelli C; Scanlan CN; Kwong PD; Jeffs SA; Jones IM; Sattentau QJ
J Mol Biol; 2010 Oct; 403(1):131-147. PubMed ID: 20800070
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
Raska M; Takahashi K; Czernekova L; Zachova K; Hall S; Moldoveanu Z; Elliott MC; Wilson L; Brown R; Jancova D; Barnes S; Vrbkova J; Tomana M; Smith PD; Mestecky J; Renfrow MB; Novak J
J Biol Chem; 2010 Jul; 285(27):20860-9. PubMed ID: 20439465
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.
Graham DR; Mitsak MJ; Elliott ST; Chen D; Whelan SA; Hart GW; Van Eyk JE
Proteomics; 2008 Dec; 8(23-24):4919-30. PubMed ID: 19072736
[TBL] [Abstract][Full Text] [Related]
11. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
Balzarini J; Van Laethem K; Hatse S; Vermeire K; De Clercq E; Peumans W; Van Damme E; Vandamme AM; Bölmstedt A; Schols D
J Virol; 2004 Oct; 78(19):10617-27. PubMed ID: 15367629
[TBL] [Abstract][Full Text] [Related]
12. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor.
Liu Y; Liu H; Kim BO; Gattone VH; Li J; Nath A; Blum J; He JJ
J Virol; 2004 Apr; 78(8):4120-33. PubMed ID: 15047828
[TBL] [Abstract][Full Text] [Related]
13. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.
Srivastava IK; Stamatatos L; Kan E; Vajdy M; Lian Y; Hilt S; Martin L; Vita C; Zhu P; Roux KH; Vojtech L; C Montefiori D; Donnelly J; Ulmer JB; Barnett SW
J Virol; 2003 Oct; 77(20):11244-59. PubMed ID: 14512572
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.
Srivastava IK; Stamatatos L; Legg H; Kan E; Fong A; Coates SR; Leung L; Wininger M; Donnelly JJ; Ulmer JB; Barnett SW
J Virol; 2002 Mar; 76(6):2835-47. PubMed ID: 11861851
[TBL] [Abstract][Full Text] [Related]
15. Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity.
Ohgimoto S; Shioda T; Mori K; Nakayama EE; Hu H; Nagai Y
J Virol; 1998 Oct; 72(10):8365-70. PubMed ID: 9733886
[TBL] [Abstract][Full Text] [Related]
16. Alteration of N-linked oligosaccharide structures of human chorionic gonadotropin beta-subunit by disruption of disulfide bonds.
Moriwaki T; Suganuma N; Furuhashi M; Kikkawa F; Tomoda Y; Boime I; Nakata M; Mizuochi T
Glycoconj J; 1997 Feb; 14(2):225-9. PubMed ID: 9111139
[TBL] [Abstract][Full Text] [Related]
17. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface.
Hu H; Shioda T; Moriya C; Xin X; Hasan MK; Miyake K; Shimada T; Nagai Y
J Virol; 1996 Nov; 70(11):7462-70. PubMed ID: 8892864
[TBL] [Abstract][Full Text] [Related]
18. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.
Shilatifard A; Merkle RK; Helland DE; Welles JL; Haseltine WA; Cummings RD
J Virol; 1993 Feb; 67(2):943-52. PubMed ID: 8419650
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of the envelope glycoprotein gp130 of simian immunodeficiency virus from sooty mangabey (Cercocebus atys).
Holschbach C; Schneider J; Geyer H
Biochem J; 1990 May; 267(3):759-66. PubMed ID: 2339985
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.
Hansen JE; Clausen H; Nielsen C; Teglbjaerg LS; Hansen LL; Nielsen CM; Dabelsteen E; Mathiesen L; Hakomori SI; Nielsen JO
J Virol; 1990 Jun; 64(6):2833-40. PubMed ID: 1692349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
